Synthesis and In-silico design of a novel silver metal ciprofloxacin compound

Sudhanshu Kumar Jha,Sneep Kumar Chaturvedi,Shivam Kumar Singh,Sunny Chauhan,Prince Chauhan,Amit,Harshit Singh,Chaitanya Kumar
DOI: https://doi.org/10.30574/wjarr.2023.18.1.0707
2023-04-30
World Journal of Advanced Research and Reviews
Abstract:Ciprofloxacin is a quinolone derivative with antibacterial properties. Quinolones, which share structural similarities with nalidixic acid, function as unidentate, bidentate, and bridging ligands during chelation. A key factor in increasing quinolones' biological activity is the presence of metal ions. Many transition metals, including Ni2+, Co2+, Ca2+, Zn2+, Ag2+, Au2+, Mn2+, Mg2+, and Fe2+, are often utilised as chelating agents. The ciprofloxacin silver ions was developed in the current study and then compared with two standard medications (ciprofloxacin and norfloxacin) and evaluated for in-silico investigations using (PDB ID: 2XCT). It was shown that the silver metal of the ciprofloxacin Analogue (L1) had a higher docking score and glide energy when compared to two standard medications like, norfloxacin and ciprofloxacin respectively. It has been demonstrated in in-silico studies that the synthesised novel silver metal of the ciprofloxacin analogue (L1) has significant potency against a wide range of bacterial and fungal diseases, making it an essential source for new antibacterial drugs that target bacterial and fungal diseases in the future.
What problem does this paper attempt to address?